Your browser doesn't support javascript.
loading
ARID1A Mutation from Targeted Next-Generation Sequencing Predicts Primary Resistance to Gemcitabine and Cisplatin Chemotherapy in Advanced Biliary Tract Cancer.
Lee, Sung Hwan; Cheon, Jaekyung; Lee, Seoyoung; Kang, Beodeul; Kim, Chan; Shim, Hyo Sup; Park, Young Nyun; Jung, Sanghoon; Choi, Sung Hoon; Choi, Hye Jin; Lee, Choong-Kun; Chon, Hong Jae.
Affiliation
  • Lee SH; Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Korea.
  • Cheon J; Division of Medical Oncology, Department of Internal Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.
  • Lee S; Department of Internal Medicine, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Korea.
  • Kang B; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.
  • Kim C; Department of Internal Medicine, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Korea.
  • Shim HS; Department of Internal Medicine, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Korea.
  • Park YN; Department of Pathology, Yonsei University College of Medicine, Seoul, Korea.
  • Jung S; Department of Pathology, Yonsei University College of Medicine, Seoul, Korea.
  • Choi SH; Department of Radiology, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Korea.
  • Choi HJ; Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Korea.
  • Lee CK; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.
  • Chon HJ; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.
Cancer Res Treat ; 55(4): 1291-1302, 2023 Oct.
Article in En | MEDLINE | ID: mdl-37139666
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bile Duct Neoplasms / Cholangiocarcinoma Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Cancer Res Treat Year: 2023 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bile Duct Neoplasms / Cholangiocarcinoma Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Cancer Res Treat Year: 2023 Document type: Article Country of publication: